CTS Spotlight at 2018 AABB Annual Meeting
Sunday, October 14, 2018 at 1:30 PM: Scientific Oral Abstract Plenary Session (BBC57) Multicenter Clinical Evaluation of a Babesia Transcription-Mediated Amplification Assay on a Fully Automated System Phillip C. Williamson, Ph.D.
Monday, October 15, 2018 at 2:30PM: (BBC2-MN3-24) Recently Acquired Hepatitis C Infections in US Blood Donors: Genotype and Geographic Distribution of NAT Yield Blood Donations across the Continental US Valerie Winkelman and Phillip C. Williamson, Ph.D.
Tuesday, October 16, 2018 at 11:45AM a: (PHP2 - TU3-23) Characteristics of HIV Infections, Including Genotypes and Drug Resistance Mutations, in Blood Donors in the US Phillip C. Williamson, Ph.D.
At CTS, we understand the impact converting to the Ortho viral marker platform has on your operation...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
As a reminder, CTS will be exhibiting this weekend at the AABB Annual Meeting in San Antonio, T...
Reminder test emails for the Health and Human Services (HHS) email notifications for WNV reactives h...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...